Conley Chee

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Todd Rosenthal, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Conley Chee:

Company Role Class Num Shares Value Price $ Report Date Ownership
Syros Pharmaceuticals, Inc. President & CEO, Director Common Stock 0 $0 $2.09 18 Nov 2024 Direct
Syros Pharmaceuticals, Inc. President & CEO, Director Restricted Stock Units 0 $0 $2.09 31 Oct 2024 Direct

Insider Reports Filed by Conley Chee

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SYRS Syros Pharmaceuticals, Inc. 18 Nov 2024 1 -$26,932 4 President & CEO, Director 20 Nov 2024, 17:00
SYRS Syros Pharmaceuticals, Inc. 31 Oct 2024 3 -$18,198 4 President & CEO, Director 04 Nov 2024, 17:01
SYRS Syros Pharmaceuticals, Inc. 10 Sep 2024 2 +$160,680 4 President & CEO, Director 12 Sep 2024, 17:00
SYRS Syros Pharmaceuticals, Inc. 31 Mar 2024 5 -$17,920 4 President & CEO, Director 02 Apr 2024, 16:52
SYRS Syros Pharmaceuticals, Inc. 02 Dec 2023 1 $0 4 President & CEO, Director 05 Dec 2023, 17:28
SYRS Syros Pharmaceuticals, Inc. 31 Oct 2023 3 -$13,329 4 Chief Commercial Officer 02 Nov 2023, 16:51
SYRS Syros Pharmaceuticals, Inc. 31 Mar 2023 3 -$1,698 4 Chief Commercial Officer 04 Apr 2023, 18:56
SYRS Syros Pharmaceuticals, Inc. 16 Feb 2023 1 $0 4 Chief Commercial Officer 21 Feb 2023, 15:19
SYRS Syros Pharmaceuticals, Inc. 11 Oct 2022 2 $0 4 Chief Commercial Officer 11 Oct 2022, 16:40
SYRS Syros Pharmaceuticals, Inc. 06 Oct 2022 2 $0 4/A Chief Commercial Officer 11 Oct 2022, 16:55
SYRS Syros Pharmaceuticals, Inc. 15 Feb 2022 2 $0 4 Chief Commercial Officer 17 Feb 2022, 15:09
SYRS Syros Pharmaceuticals, Inc. 27 Sep 2021 1 $0 4 Chief Commercial Officer 28 Sep 2021, 16:24
SYRS Syros Pharmaceuticals, Inc. 27 Sep 2021 0 $0 3 Chief Commercial Officer 28 Sep 2021, 16:21